X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
animals (14) 14
index medicus (14) 14
abatacept (11) 11
immunology (11) 11
t-lymphocytes, cytotoxic - immunology (10) 10
chemical and pharmacologic phenomena (8) 8
dendritic cells (8) 8
female (8) 8
lymphocytes (8) 8
antigens (7) 7
t cells (7) 7
adult (6) 6
care and treatment (6) 6
ctla-4 antigen (6) 6
disease (6) 6
medicine, research & experimental (6) 6
mice (6) 6
antigens, cd (5) 5
costimulation (5) 5
ctla-4 (5) 5
genetic aspects (5) 5
immune tolerance (5) 5
male (5) 5
middle aged (5) 5
antigens, differentiation - immunology (4) 4
apoptosis (4) 4
cells, cultured (4) 4
cytokines (4) 4
dendritic cells - immunology (4) 4
development and progression (4) 4
expression (4) 4
flow cytometry (4) 4
health aspects (4) 4
hemic and immune systems (4) 4
immune response (4) 4
immune system (4) 4
immunoglobulins (4) 4
mice, inbred balb c (4) 4
original (4) 4
original articles (4) 4
review (4) 4
transplantation (4) 4
activation (3) 3
allograft-rejection (3) 3
antibodies, monoclonal - immunology (3) 3
articles (3) 3
asthma (3) 3
cd28 (3) 3
cd28 antigens - immunology (3) 3
cells (3) 3
ctla-4 antigen - genetics (3) 3
cytotoxic t lymphocyte-associated antigen 4 (3) 3
cytotoxicity (3) 3
hematology (3) 3
immunoconjugates - therapeutic use (3) 3
immunotherapy (3) 3
in-vivo (3) 3
internal medicine (3) 3
lymphocyte activation (3) 3
medical research (3) 3
oncology (3) 3
quality of life (3) 3
research (3) 3
rheumatoid arthritis (3) 3
stem cells (3) 3
therapy (3) 3
transplants & implants (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
aged (2) 2
airway inflammation (2) 2
allergens - immunology (2) 2
allergy (2) 2
analysis (2) 2
animal model (2) 2
antibodies (2) 2
antibodies, monoclonal - pharmacology (2) 2
antigen-antibody reactions (2) 2
antigens, cd - immunology (2) 2
antigens, differentiation - chemistry (2) 2
antirheumatic agents - therapeutic use (2) 2
antitumor immunity (2) 2
arthritis (2) 2
arthritis, rheumatoid - drug therapy (2) 2
asian continental ancestry group - genetics (2) 2
association (2) 2
atopic asthma (2) 2
autoimmune diseases (2) 2
autoimmune diseases - immunology (2) 2
b-cell (2) 2
b7-1 antigen - immunology (2) 2
b7-1 antigen - metabolism (2) 2
biochemistry & molecular biology (2) 2
biotechnology & applied microbiology (2) 2
blockade (2) 2
cancer research (2) 2
cardiac allografts (2) 2
cd28 antigens - genetics (2) 2
cd4-positive t-lymphocytes - immunology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Experimental Immunology, ISSN 0009-9104, 04/2013, Volume 172, Issue 1, pp. 113 - 120
Allergen-specific immunotherapy (SIT) is the only treatment for allergic diseases that targets allergen-specific T helper type 2 (Th2) cells, which are the... 
TRANSCRIPTION FACTORS | airway hyperreactivity | allergen immunotherapy | TOLERANCE INDUCTION | DENDRITIC CELLS | FOLLOW-UP | CTLA-4-Ig in allergy | MURINE MODEL | B-CELL | adjuvant | IDO | MOUSE MODEL | ASTHMA | CTLA-4 | CTLA‐4‐Ig in allergy | Airway hyperreactivity | Adjuvant | Allergen immunotherapy | IMMUNOLOGY | Indoleamine-Pyrrole 2,3,-Dioxygenase - genetics | Adjuvants, Immunologic - administration & dosage | Ovalbumin - immunology | Indoleamine-Pyrrole 2,3,-Dioxygenase - deficiency | Th2 Cells - immunology | Indoleamine-Pyrrole 2,3,-Dioxygenase - immunology | Immunoconjugates - administration & dosage | Th2 Cells - drug effects | Immunoglobulin E - blood | Immunoconjugates - immunology | Allergens - administration & dosage | Immunoglobulin E - immunology | Abatacept | Allergens - immunology | CD28 Antigens - genetics | Asthma - immunology | Th2 Cells - pathology | Cytokines - immunology | T-Lymphocytes, Cytotoxic - immunology | Gene Expression | Immune Tolerance | CD28 Antigens - immunology | Asthma - drug therapy | Mice, Knockout | Animals | Ovalbumin - administration & dosage | T-Lymphocytes, Cytotoxic - metabolism | Mice | Mice, Inbred BALB C | Asthma - pathology | Cytokines - biosynthesis | Desensitization, Immunologic - methods | Antigen-antibody reactions | Autoimmunity | Allergens | Analysis | Immunotherapy | Immunoglobulin G | Immunoglobulin E | T cells | Asthma | Antigens | Medical research | Cytotoxicity | Rodents | Original
Journal Article
Journal Article
by Zou, CP and Wei, KN and Zhao, YZ and Li, XY and Wang, P and Zheng, C and Jiao, Y and Zhao, YP
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, ISSN 1940-5901, 2018, Volume 11, Issue 5, pp. 4723 - 4729
This study aimed to investigate the influence of Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin (CTLA-4-Ig) on the hemodynamics and stiffness of... 
MEDICINE, RESEARCH & EXPERIMENTAL | kidney | ultrasonic elastography | type 2 diabetes | THERAPY | Cytotoxic T lymphocyte associated antigen 4 immunoglobulin | podocyte | DISEASE | PERFUSION | MELLITUS | color Doppler ultrasound | DOPPLER
Journal Article
Cytotherapy, ISSN 1465-3249, 2011, Volume 13, Issue 10, pp. 1269 - 1280
Journal Article
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2012, Volume 87, Issue 7, pp. 659 - 673
Abstract The past decade has brought important advances in the understanding of rheumatoid arthritis and its management and treatment. New classification... 
Internal Medicine | C-REACTIVE PROTEIN | PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | ERYTHROCYTE SEDIMENTATION-RATE | MODIFYING ANTIRHEUMATIC DRUG | DISEASE-ACTIVITY INDEX | DOUBLE-BLIND | STANDARD CLINICAL CARE | RANDOMIZED CONTROLLED-TRIAL | CONGESTIVE-HEART-FAILURE | RAPID RADIOGRAPHIC PROGRESSION | Prognosis | Humans | Methotrexate - therapeutic use | Arthritis, Rheumatoid - complications | Abatacept | Time Factors | Arthritis, Rheumatoid - drug therapy | Synovitis - etiology | Anti-Inflammatory Agents - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - pharmacology | Drug Therapy, Combination | Arthritis, Rheumatoid - diagnosis | Arthritis, Rheumatoid - physiopathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Diagnosis, Differential | Antibodies, Monoclonal, Humanized - therapeutic use | Anti-Inflammatory Agents - pharmacology | Comorbidity | Rituximab | Joints - pathology | Treatment Outcome | Evidence-Based Medicine | Remission Induction | Arthritis, Rheumatoid - pathology | Randomized Controlled Trials as Topic | Arthritis, Rheumatoid - therapy | Quality of Life | Referral and Consultation | Isoxazoles - therapeutic use | Prednisone - therapeutic use | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Causes of | Practice guidelines (Medicine) | Care and treatment | Diagnosis | Rheumatoid arthritis | Patient outcomes | ACPA, anti–citrullinated protein antibody | TNF, tumor necrosis factor | BeSt, Behandel-Strategieën [trial] | CDAI, Clinical Disease Activity Index | SSZ, sulfasalazine | MTX, methotrexate | EULAR, European League Against Rheumatism | HCQ, hydroxychloroquine | TEAR, Treatment of Early Aggressive Rheumatoid Arthritis [study] | DMARD, disease-modifying antirheumatic drug | ACR, American College of Rheumatology | CRP, C-reactive protein | Diagnosis and Treatment Guidelines | My treatment approach | CTLA-4:Ig, cytotoxic T lymphocyte–associated antigen 4:immunoglobulin fusion protein | DAS28, Disease Activity Score in 28 joints | SDAI, Simplified Disease Activity Index
Journal Article
Journal Article
Journal Article